The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
Conditions: Diabetes Mellitus, Type 2 Sponsors: Aalborg University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Conditions: Oral Submucous Fibrosis Interventions: Drug: Metformin Hydrochloride; Drug: betamethasone dipropionate; Drug: Pentoxifylline Sponsors: Ziauddin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

Vitamin D With Omega-3 or Metformin in Osteoarthritis
Conditions: Osteoarthritis Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Omega-3; Drug: Metformin; Dietary Supplement: Placebo Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
Conditions: Type 2 Diabetes Mellitus (T2DM) Interventions: Drug: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets; Drug: Dapagliflozin tablets and Metformin HCl extended-release tablets Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

PCOS Patients Immune Status Evaluation
Conditions: Polycystic Ovary Syndrom; Metformin; Immune Function Interventions: Diagnostic Test: Detect the immune function of peripheral blood samples Sponsors: Shanghai 10th People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
Conditions: Metabolic Disturbance; Hyperprolactinemia; Schizophrenia Interventions: Drug: Metformin Sponsors: Taipei Medical University Hospital; Taipei Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

PCOS Immune Function Predicts Metformin Efficacy
Conditions: Polycystic Ovary Syndrome; Metformin; Immune Function Interventions: Drug: Metformin Sponsors: Shanghai 10th People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Conditions: Type 2 Diabetes Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
Conditions: Steroid-Induced Diabetes; Steroid Induced Hyperglycemia Interventions: Drug: Semaglutide Oral Product; Drug: Metformin Oral Tablet; Drug: Placebo Sponsors: Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Conditions: Type 2 Diabetes Interventions: Drug: Retatrutide; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Effect of Continuing Versus Holding Metformin During Hospitalizations.
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Metformin Sponsors: University of Illinois at Chicago; Emily Hanners; Dulal Bhaumik; Avisek Datta; Peggy Choye; Hailey Soni; Annesti Elmasri; Julie Jun; Colin Goodman Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials

Metformin Use in Patients Undergoing Total Joint Replacement Surgery
Conditions: Hyperglycemia Interventions: Drug: Metformin; Other: Placebo Sponsors: Oregon Health and Science University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Conditions: Asthma; Asthma Chronic; Overweight and Obesity Interventions: Drug: Metformin hydrochloride extended-release tablets; Drug: Visually identical placebo Metformin hydrochloride extended-release tablets Sponsors: Johns Hopkins University; Baylor College of Medicine; National Heart, Lung, and Blood Institute (NHLBI); Temple University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

Effectiveness of Antidiabetic Treatment Applied in Childhood Obesity
Conditions: Childhood Obesity; Insulin Resistance Interventions: Drug: Metformin Sponsors: H ÜMEYRA ACIKAN Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials

Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Retatrutide; Drug: Semaglutide Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials